Cleveland Clinic's First Biotech Company
Cleveland Clinic's first biotech company
The Cleveland Clinic has established its first biotech company, Cellect Therapeutics Inc., based on an antisense oligonucleotide conjugated with the enzyme activator 2-5A.
The Castle Group arranged a private placement of $5 million from qualified retail investors, and has
